399 related articles for article (PubMed ID: 24773992)
1. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es study.
Valdés S; García-Torres F; Maldonado-Araque C; Goday A; Calle-Pascual A; Soriguer F; Castaño L; Catalá M; Gomis R; Rojo-Martínez G;
Rev Esp Cardiol (Engl Ed); 2014 Jun; 67(6):442-8. PubMed ID: 24863592
[TBL] [Abstract][Full Text] [Related]
3. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study.
Rojo-Martínez G; Soriguer F; Colomo N; Calle A; Goday A; Bordiú E; Delgado E; Menéndez E; Ortega E; Urrutia I; Girbés J; Castaño L; Catalá M; Gaztambide S; Valdés S;
Eur J Clin Invest; 2013 Jan; 43(1):1-10. PubMed ID: 23134526
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
[TBL] [Abstract][Full Text] [Related]
5. [Validity of the MONICA cardiovascular questionnaire compared with clinical records].
Baena-Díez JM; Alzamora-Sas MT; Grau M; Subirana I; Vila J; Torán P; García-Navarro Y; Bermúdez-Chillida N; Alegre-Basagaña J; Viozquez-Meia M; Marrugat J
Gac Sanit; 2009; 23(6):519-25. PubMed ID: 19487052
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting levels of urinary albumin excretion in the general population of Spain: the Di@bet.es study.
Gutiérrez-Repiso C; Rojo-Martínez G; Soriguer F; García-Fuentes E; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Serrano-Rios M; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gutiérrez G; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Catalá M; Castell C; Castaño L; Casamitjana R; Carmena R; Calle-Pascual A; Bordiú E; Bosch-Comas A
Clin Sci (Lond); 2013 Feb; 124(4):269-77. PubMed ID: 22970892
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the di@bet.es study.
Martinez-Hervas S; Carmena R; Ascaso JF; Real JT; Masana L; Catalá M; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Soriguer F; Serrano-Rios M; Rojo-Martínez G; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Castell C; Castaño L; Casamitjana R; Calle-Pascual A; Bordiú E
Clin Investig Arterioscler; 2014; 26(3):107-14. PubMed ID: 24461346
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study.
Soriguer F; Goday A; Bosch-Comas A; Bordiú E; Calle-Pascual A; Carmena R; Casamitjana R; Castaño L; Castell C; Catalá M; Delgado E; Franch J; Gaztambide S; Girbés J; Gomis R; Gutiérrez G; López-Alba A; Martínez-Larrad MT; Menéndez E; Mora-Peces I; Ortega E; Pascual-Manich G; Rojo-Martínez G; Serrano-Rios M; Valdés S; Vázquez JA; Vendrell J
Diabetologia; 2012 Jan; 55(1):88-93. PubMed ID: 21987347
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of treatment for diabetes during 1997-2007, and trends in cardiovascular risk factors between 2001 and 2007 according to diabetic treatment, in the IPC (Investigations Préventives et Cliniques; Preventive and Clinical Investigations) cohort.
Thomas F; Eschwege E; Bean K; Pannier B; Danchin N
Diabetes Metab; 2013 Sep; 39(4):343-8. PubMed ID: 23642643
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study.
Menéndez E; Delgado E; Fernández-Vega F; Prieto MA; Bordiú E; Calle A; Carmena R; Castaño L; Catalá M; Franch J; Gaztambide S; Girbés J; Goday A; Gomis R; López-Alba A; Martínez-Larrad MT; Mora-Peces I; Ortega E; Rojo-Martínez G; Serrano-Ríos M; Urrutia I; Valdés S; Vázquez JA; Vendrell J; Soriguer F
Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):572-8. PubMed ID: 26979767
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study.
Wakkee M; Meijer W; Neumann HA; Herings RM; Nijsten T
Acta Derm Venereol; 2009; 89(5):476-83. PubMed ID: 19734972
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, management and control of diabetes mellitus and associated risk factors in primary health care in Portugal.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2010 Apr; 29(4):509-37. PubMed ID: 20734573
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clustering of cardiovascular risk factors among healthy adults in a Chinese population: the MJ Health Screening Center Study in Taiwan.
Wu DM; Pai L; Chu NF; Sung PK; Lee MS; Tsai JT; Hsu LL; Lee MC; Sun CA
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1189-95. PubMed ID: 11477504
[TBL] [Abstract][Full Text] [Related]
16. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
[TBL] [Abstract][Full Text] [Related]
18. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar.
Bener A; Zirie M; Janahi IM; Al-Hamaq AO; Musallam M; Wareham NJ
Diabetes Res Clin Pract; 2009 Apr; 84(1):99-106. PubMed ID: 19261345
[TBL] [Abstract][Full Text] [Related]
20. The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes.
Zhang Y; Vitry A; Caughey G; Roughead EE; Ryan P; Gilbert A; Shakib S; McDermott R
Diabetes Res Clin Pract; 2011 Jan; 91(1):115-20. PubMed ID: 21067836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
